InvestorsHub Logo
Followers 29
Posts 2446
Boards Moderated 0
Alias Born 11/22/2010

Re: nealhugh post# 1332

Wednesday, 02/17/2021 8:10:32 PM

Wednesday, February 17, 2021 8:10:32 PM

Post# of 1524
Excellent Neil, I still like the recommendation I gave you on SEELOS Therapeutics.

Ketamine is very much still under the radar for most US investors. It's a very strong med and Johnson&Johnson's strangle hold on the scripts will come to an end. I'm watching for $2.90-$3.40 and will probably buy back in. I've made 4 round trips on it in the last 2 months for over $20K in profits. big gainer ;)

patient trials are due in April/May.

my only concern with a buy & hold strategy is a secondary raise, even though they just did one... pharmas love to grab money when it's sitting on the table.... ramping up for commercialization is pricey

This will be trading $5-$10 soon enough. either before or after data on patient trials

** for others, sorry to post on here, I can't send Private Messages

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLSH News